Synergy Spine Closes $30 Million Financing

Synergy Spine Solutions closed a Series A equity financing of $30 million.

Proceeds will be used to complete enrollment of Synergy’s U.S. IDE 2-level clinical trial, continue patient follow-up on 1-level and 2-level clinical trials, Premarket Approval applications and continued ex-U.S. commercialization of the company’s cervical disc...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us